What I do

Medical Neurotechnology · Quality · Capital · Field Architecture

I work on making neurotech work.

Cross-pollinating viewpoints between quality engineering, writing, and funding to have real-time hands-on knowledge of how the field works and how it is evolving.

My flagship canon, MECHANISMS, names the hidden patterns that cause capable teams to produce value that goes uncaptured, good research to stall, and promising devices to never reach patients.

Resources Work
About

Building at the
intersection of fields

I earned a PhD in neuroscience from the University of Michigan. My research focused on brain rhythms and how neural circuits work together. Today I work across quality engineering, venture investing, and strategy in neurotechnology.

My work turns hard-won knowledge into tools and resources others can use.

A note on how I got here: as a child, I wrote a 45-page typed documentary on human behavior just because I was curious. My dream was to be a scientist and write books about my inventions. I also lived and trained at the Ann Arbor Zen Buddhist Temple for 22 months during graduate school. You cannot meditate your way through the FDA, but you can learn to see systems clearly.
Sharena Rice speaking at UCLA David Geffen School of Medicine
Speaking at UCLA David Geffen
School of Medicine
55
Named structural claims in MECHANISMS
30+
Published resources in neurotech
14K+
LinkedIn followers
5
Active positions in the field
Resources

Canon and reference
infrastructure

Structural diagnostics · Five volumes
MECHANISMS
A Systems Account of Medical Neurotechnology
A five-volume canon that names the structural patterns behind why medical neurotechnology fails. Not because people are not smart or working hard, but because systems build in the wrong incentives, authority structures, and blind spots before anyone makes a single product decision. Written for operators, builders, and funders who already sense something is broken but do not yet have the language for it.
Read MECHANISMS →
CC BY-NC-SA 4.0 · Free to share with attribution
Field navigation · Five volumes
NAVIGATIONS
Making the Odds Visible
A five-volume canon. NAVIGATIONS gives people practical tools for moving forward when their path is unclear and the stakes are real. The volumes cover agency, authority, working through difficulty, staying aligned, and building something that lasts.
Following MECHANISMS · Expected Q3 2026
CC BY-NC-SA 4.0 · Free to share with attribution
Standards and governance reference
Neurotechnology Standards & Governance
A Curated Reference for Innovators
A map of the standards bodies, regulators, and ethics initiatives that shape how neurotechnology products are developed and approved worldwide. Used by product teams, researchers, and program managers who need to find the right frameworks early.
View resource →
Reimbursement reference
Navigating the Neurotechnology Reimbursement Maze
From Clearance to Coverage
Article on how neurotechnology products move from FDA clearance to insurance coverage to patient access. Designed for developers and teams who need to understand the reimbursement landscape before it becomes a late-stage surprise.
View resource →
Work

Current positions

Sanmai Technologies PBC
Senior Quality Engineer
Joined Sanmai in 2022. Building the quality systems this transcranial focused ultrasound neuromodulation startup needs to get a device through FDA review. This includes design controls, testing protocols, verification, and the documentation that holds up under audit.
Kaleida Capital
Venture Fellow
Investment team member at a venture fund backing the future of neurotech and computation. Producing due diligence frameworks that enable the fund evaluate companies with more depth and speed.
Neuradaptive
Strategy Consultant
Quality, regulatory, and commercialization strategy for an AI-native neuromodulation implant company. Building the right foundations before they scale.
Neurotech Reports Writing about medical devices for professional audiences
Since 2022 · Acquired by Cambridge Innovation Institute
Foresight Institute Grant advising
Since 2024
Connect

Follow for neurotech. Stay for systems, incentives, and what actually scales.

I am heads-down building and selective about meetings. If you reach out, please include a concrete ask.

LinkedIn Email